NCT01553747

Brief Summary

The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of eluxadoline (JNJ-27018966) compared with placebo in the treatment of participants with diarrhea-predominant irritable bowel syndrome.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,146

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started May 2012

Geographic Reach
4 countries

253 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 14, 2012

Completed
3 months until next milestone

Study Start

First participant enrolled

May 29, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 9, 2014

Completed
4.6 years until next milestone

Results Posted

Study results publicly available

July 30, 2018

Completed
Last Updated

July 30, 2018

Status Verified

July 1, 2018

Enrollment Period

1.6 years

First QC Date

March 8, 2012

Results QC Date

June 11, 2018

Last Update Submit

July 27, 2018

Conditions

Keywords

Irritable bowel syndrome with diarrheaIrritable bowel syndromeDiarrhea predominant irritable bowel syndromeColonic diseasesColonic diseases, functionalDigestive system diseaseGastrointestinal diseaseIntestinal diseaseColonic pseudo-obstructionDiarrheaSigns and symptoms, Digestive

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain and Daily Stool Consistency Scores

    Composite responders were defined as participants who met the daily response criteria for at least 50% of the days with diary entries during the interval of interest. A participant must had met both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Daily stool consistency response: Bristol Stool Scale (BSS) score \<5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain. Bristol stool scale was defined as 7-point Scale in which a score of 1 = separate hard lumps, 2 = sausage shaped but lumpy, 3 = sausage-like with cracks on the surface, 4 = sausage-like but smooth and soft, 5 = soft blobs with clear cut edges, 6 = fluffy pieces with ragged edges, and 7 = watery with no solid pieces.

    Up to 12 weeks

Secondary Outcomes (13)

  • Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain and Daily Stool Consistency Scores

    Up to 26 weeks

  • Percentage of Participants Who Were Pain Responders In Daily Worst Abdominal Pain Scores by Intervals

    12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)

  • Percentage of Participants Who Were Responders In Daily Stool Consistency Scores by Intervals

    12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)

  • Percentage of Participants Who Were Responders In Irritable Bowel Syndrome, Diarrhea Predominant (IBS-d) Global Symptom Scale by Intervals

    12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)

  • Percentage of Participants Who Were Responders to the Irritable Bowel Syndrome Quality of Life Measure (IBS-QoL) Scale

    Weeks 4, 8, 12, 18, 26 and 30 (End of Treatment [EOT])

  • +8 more secondary outcomes

Study Arms (3)

Eluxadoline 75 mg

EXPERIMENTAL

Eluxadoline 75 mg tablets, orally, twice daily for up to 26 weeks period.

Drug: Eluxadoline

Eluxadoline 100 mg

EXPERIMENTAL

Eluxadoline 100 mg tablets, orally, twice daily for up to 26 weeks period.

Drug: Eluxadoline

Placebo

PLACEBO COMPARATOR

Eluxadoline placebo matching tablets, orally, twice daily for up to 26 weeks period.

Drug: Placebo

Interventions

Oral tablets twice daily

Also known as: JNJ-27018966
Eluxadoline 100 mgEluxadoline 75 mg

Oral tablets twice daily

Placebo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is 18 to 80 years old
  • Participant has a diagnosis of irritable bowel syndrome (IBS) with a subtype of diarrhea defined by the Rome III criteria.
  • \. Participant has had a colonoscopy performed:
  • Within 10 years prior to Prescreening if participant is at least 50 years of age (sigmoidoscopy, double contrast barium enema, or computed tomography (CT) colonography within the past 5 years is acceptable)
  • Since the onset (if applicable) of any of the following alarm features for participants of any age
  • Participant has documented weight loss within the past 6 months
  • Participant has nocturnal symptoms
  • Participant has a familial history of first-degree relatives with colon cancer
  • Participant has blood mixed with their stool (excluding blood from hemorrhoids).
  • \. Female participants must be:
  • Postmenopausal, defined as 52 years or older and amenorrheic for at least 2 years at Prescreening,
  • Surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy),
  • Abstinent, or
  • If sexually active, be practicing an effective method of birth control.

You may not qualify if:

  • Participant has a diagnosis of IBS with a subtype of constipation, mixed IBS, or unsubtyped IBS by the Rome III criteria.
  • Participant has a history of inflammatory or immune-mediated gastrointestinal (GI) disorders including inflammatory bowel disease (ie, Crohn's disease, ulcerative colitis) and celiac disease.
  • Participant has a history of diverticulitis within 3 months prior to Prescreening.
  • Participant has a history of intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic colitis, or impaired intestinal circulation (eg, aortoiliac disease).
  • Participant has any of the following surgical history:
  • Cholecystectomy with any history of post cholecystectomy biliary tract pain
  • Any abdominal surgery within the 3 months prior to Prescreening
  • Participant has a history of major gastric, hepatic, pancreatic, or intestinal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post surgery are allowed)
  • Other protocol-specific eligibility criteria may apply.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (253)

Furiex Research Site

Birmingham, Alabama, 35209, United States

Location

Furiex Research Site

Birmingham, Alabama, 35242, United States

Location

Furiex Research Site

Decatur, Alabama, 35603, United States

Location

Furiex Research Site

Huntsville, Alabama, 35801, United States

Location

Furiex Research Site

Mobile, Alabama, 36608, United States

Location

Furiex Research Site

Montgomery, Alabama, 36109, United States

Location

Furiex Research Site

Sheffield, Alabama, 35660, United States

Location

Furiex Research Site

Tuscaloosa, Alabama, 35401, United States

Location

Furiex Research Site

Glendale, Arizona, 85306, United States

Location

Furiex Research Site

Glendale, Arizona, 85308, United States

Location

Furiex Research Site

Mesa, Arizona, 85206, United States

Location

Furiex Research Site

Phoenix, Arizona, 85023, United States

Location

Furiex Research Site

Phoenix, Arizona, 85032, United States

Location

Furiex Research Site

Tucson, Arizona, 85704, United States

Location

Furiex Research Site

Tucson, Arizona, 85712, United States

Location

Furiex Research Site

Jonesboro, Arkansas, 72401, United States

Location

Furiex Research Site

Little Rock, Arkansas, 72205, United States

Location

Furiex Research Site

Sherwood, Arkansas, 72120, United States

Location

Furiex Research Site

Anaheim, California, 92801, United States

Location

Furiex Research Site

Chula Vista, California, 91910, United States

Location

Furiex Research Site

Encinitas, California, 92024, United States

Location

Furiex Research Site

Garden Grove, California, 92840, United States

Location

Furiex Research Site

Huntington Beach, California, 92647, United States

Location

Furiex Research Site

Irvine, California, 92604, United States

Location

Furiex Research Site

La Mesa, California, 91942, United States

Location

Furiex Research Site

La Mirada, California, 90638, United States

Location

Furiex Research Site

Laguna Hills, California, 92653, United States

Location

Furiex Research Site

Lakewood, California, 90805, United States

Location

Furiex Research Site

Lincoln, California, 95648, United States

Location

Furiex Research Site

Loma Linda, California, 92354, United States

Location

Furiex Research Site

Lomita, California, 90717, United States

Location

Furiex Research Site

Long Beach, California, 90806, United States

Location

Furiex Research Site

Los Angeles, California, 90045, United States

Location

Furiex Research Site

Newport Beach, California, 92663, United States

Location

Furiex Research Site

North Hollywood, California, 91606, United States

Location

Furiex Research Site

Northridge, California, 91325, United States

Location

Furiex Research Site

Pasadena, California, 91105, United States

Location

Furiex Research Site

Sacramento, California, 95817, United States

Location

Furiex Research Site

San Diego, California, 92103, United States

Location

Furiex Research Site

San Diego, California, 92105, United States

Location

Furiex Research Site

Santa Ana, California, 92701, United States

Location

Furiex Research Site

Ventura, California, 93003, United States

Location

Furiex Research Site

Walnut Creek, California, 94598, United States

Location

Furiex Research Site

Denver, Colorado, 80211, United States

Location

Furiex Research Site

Denver, Colorado, 80246, United States

Location

Furiex Research Site

Boca Raton, Florida, 33428, United States

Location

Furiex Research Site

Boynton Beach, Florida, 33426, United States

Location

Furiex Research Site

Bradenton, Florida, 34208, United States

Location

Furiex Research Site

Brooksville, Florida, 34601, United States

Location

Furiex Research Site

Clearwater, Florida, 33759, United States

Location

Furiex Research Site

Cooper City, Florida, 33024, United States

Location

Furiex Research Site

Coral Springs, Florida, 33065, United States

Location

Furiex Research Site

Eustis, Florida, 32726, United States

Location

Furiex Research Site

Fort Lauderdale, Florida, 33308, United States

Location

Furiex Research Site

Hallandale, Florida, 33009, United States

Location

Furiex Research Site

Hialeah, Florida, 33016, United States

Location

Furiex Research Site

Jacksonville, Florida, 32205, United States

Location

Furiex Research Site

Jupiter, Florida, 33458, United States

Location

Furiex Research Site

Lauderdale Lakes, Florida, 33319, United States

Location

Furiex Research Site

Melbourne, Florida, 32901, United States

Location

Furiex Research Site

Miami, Florida, 33015, United States

Location

Furiex Research Site

Miami, Florida, 33125, United States

Location

Furiex Research Site

Miami, Florida, 33126, United States

Location

Furiex Research Site

Miami, Florida, 33133, United States

Location

Furiex Research Site

Miami, Florida, 33135, United States

Location

Furiex Research Site

Miami, Florida, 33144, United States

Location

Furiex Research Site

Miami, Florida, 33155, United States

Location

Furiex Research Site

Miami, Florida, 33183, United States

Location

Furiex Research Site

Miramar, Florida, 33025, United States

Location

Furiex Research Site

New Port Richey, Florida, 34652, United States

Location

Furiex Research Site

Orlando, Florida, 32806, United States

Location

Furiex Research Site

Plant City, Florida, 33563, United States

Location

Furiex Research Site

Port Orange, Florida, 32127, United States

Location

Furiex Research Site

South Miami, Florida, 33143, United States

Location

Furiex Research Site

St. Petersburg, Florida, 33705, United States

Location

Furiex Research Site

St. Petersburg, Florida, 33709, United States

Location

Furiex Research Site

Tampa, Florida, 33607, United States

Location

Furiex Research Site

Wellington, Florida, 33414, United States

Location

Furiex Research Site

Winter Haven, Florida, 33880, United States

Location

Furiex Research Site

Winter Park, Florida, 32792, United States

Location

Furiex Research Site

Alpharetta, Georgia, 30005, United States

Location

Furiex Research Site

Athens, Georgia, 30606, United States

Location

Furiex Research Site

Atlanta, Georgia, 30308, United States

Location

Furiex Research Site

Atlanta, Georgia, 30338, United States

Location

Furiex Research Site

Dunwoody, Georgia, 30338, United States

Location

Furiex Research Site

Lawrenceville, Georgia, 30046, United States

Location

Furiex Research Site

Macon, Georgia, 31201, United States

Location

Furiex Research Site

Marietta, Georgia, 30066, United States

Location

Furiex Research Site

Norcross, Georgia, 30092, United States

Location

Furiex Research Site

Savannah, Georgia, 31404, United States

Location

Furiex Research Site

Stockbridge, Georgia, 30281, United States

Location

Furiex Research Site

Boise, Idaho, 83704, United States

Location

Furiex Research Site

Eagle, Idaho, 83616, United States

Location

Furiex Research Site

Idaho Falls, Idaho, 83404, United States

Location

Furiex Research Site

Addison, Illinois, 60101, United States

Location

Furiex Research Site

Chicago, Illinois, 60612, United States

Location

Furiex Research Site

Chicago, Illinois, 60622, United States

Location

Furiex Research Site

Evergreen Park, Illinois, 60805, United States

Location

Furiex Research Site

Hammond, Illinois, 46324, United States

Location

Furiex Research Site

Springfield, Illinois, 62703, United States

Location

Furiex Research Site

Brownsburg, Indiana, 46112, United States

Location

Furiex Research Site

Evansville, Indiana, 47714, United States

Location

Furiex Research Site

Granger, Indiana, 46530, United States

Location

Furiex Research Site

Clive, Iowa, 50325, United States

Location

Furiex Research Site

Pratt, Kansas, 67124, United States

Location

Furiex Research Site

Shawnee Mission, Kansas, 66218, United States

Location

Furiex Research Site

Topeka, Kansas, 66606, United States

Location

Furiex Research Site

Lexington, Kentucky, 40503, United States

Location

Furiex Research Site

Lexington, Kentucky, 40504, United States

Location

Furiex Research Site

Owensboro, Kentucky, 42303, United States

Location

Furiex Research Site

Paducah, Kentucky, 42003, United States

Location

Furiex Research Site

Lake Charles, Louisiana, 70601, United States

Location

Furiex Research Site

Monroe, Louisiana, 71201, United States

Location

Furiex Research Site

Hagerstown, Maryland, 21742, United States

Location

Furiex Research Site

Hollywood, Maryland, 20636, United States

Location

Furiex Research Site

Boston, Massachusetts, 02115, United States

Location

Furiex Research Site

Boston, Massachusetts, 02131, United States

Location

Furiex Research Site

Brockton, Massachusetts, 02302, United States

Location

Furiex Research Site

Watertown, Massachusetts, 02472, United States

Location

Furiex Research Site

Ann Arbor, Michigan, 48106, United States

Location

Furiex Research Site

Bay City, Michigan, 48706, United States

Location

Furiex Research Site

Cadillac, Michigan, 49601, United States

Location

Furiex Research Site

Grand Rapids, Michigan, 49506, United States

Location

Furiex Research Site

Kalamazoo, Michigan, 49009, United States

Location

Furiex Research Site

Troy, Michigan, 48098, United States

Location

Furiex Research Site

Ypsilanti, Michigan, 48197, United States

Location

Furiex Research Site

Plymouth, Minnesota, 55446, United States

Location

Furiex Research Site

Biloxi, Mississippi, 39531, United States

Location

Furiex Research Site

City of Saint Peters, Missouri, 63376, United States

Location

Furiex Research Site

Hazelwood, Missouri, 63042, United States

Location

Furiex Research Site

St Louis, Missouri, 63122, United States

Location

Furiex Research Site

St Louis, Missouri, 63128, United States

Location

Furiex Research Site

St Louis, Missouri, 63141, United States

Location

Furiex Research Site

Billings, Montana, 59101, United States

Location

Furiex Research Site

Bellevue, Nebraska, 68005, United States

Location

Furiex Research Site

Elkhorn, Nebraska, 68022, United States

Location

Furiex Research Site

Lincoln, Nebraska, 68510, United States

Location

Furiex Research Site

Omaha, Nebraska, 68134, United States

Location

Furiex Research Site

Omaha, Nebraska, 68144, United States

Location

Furiex Research Site

Las Vegas, Nevada, 89123, United States

Location

Furiex Research Site

Reno, Nevada, 89511, United States

Location

Furiex Research Site

Lebanon, New Hampshire, 03756, United States

Location

Furiex Research Site

Blackwood, New Jersey, 08012, United States

Location

Furiex Research Site

Edison, New Jersey, 08817, United States

Location

Furiex Research Site

Elizabeth, New Jersey, 07201, United States

Location

Furiex Research Site

Marlton, New Jersey, 08053, United States

Location

Furiex Research Site

Albuquerque, New Mexico, 87102, United States

Location

Furiex Research Site

Albuquerque, New Mexico, 87108, United States

Location

Furiex Research Site

Albuquerque, New Mexico, 87109, United States

Location

Furiex Research Site

Flushing, New York, 11367, United States

Location

Furiex Research Site

Hollis, New York, 11423, United States

Location

Furiex Research Site

Mineola, New York, 11501, United States

Location

Furiex Research Site

New York, New York, 10016, United States

Location

Furiex Research Site

Chapel Hill, North Carolina, 27599, United States

Location

Furiex Research Site

Dunn, North Carolina, 28334, United States

Location

Furiex Research Site

Greensboro, North Carolina, 27403, United States

Location

Furiex Research Site

Huntersville, North Carolina, 28078, United States

Location

Furiex Research Site

Kinston, North Carolina, 28501, United States

Location

Furiex Research Site

Wilmington, North Carolina, 28403, United States

Location

Furiex Research Site

Winston-Salem, North Carolina, 27103, United States

Location

Furiex Research Site

Winston-Salem, North Carolina, 27106, United States

Location

Furiex Research Site

Akron, Ohio, 44302, United States

Location

Furiex Research Site

Beavercreek, Ohio, 45431, United States

Location

Furiex Research Site

Cincinnati, Ohio, 45224, United States

Location

Furiex Research Site

Cincinnati, Ohio, 45242, United States

Location

Furiex Research Site

Cincinnati, Ohio, 45245, United States

Location

Furiex Research Site

Cincinnati, Ohio, 45267, United States

Location

Furiex Research Site

Cleveland, Ohio, 44122, United States

Location

Furiex Research Site

Columbus, Ohio, 43212, United States

Location

Furiex Research Site

Columbus, Ohio, 43214, United States

Location

Furiex Research Site

Columbus, Ohio, 43235, United States

Location

Furiex Research Site

Dayton, Ohio, 45432, United States

Location

Furiex Research Site

Dayton, Ohio, 45439, United States

Location

Furiex Research Site

Groveport, Ohio, 43125, United States

Location

Furiex Research Site

Kettering, Ohio, 45429, United States

Location

Furiex Research Site

Lima, Ohio, 45806, United States

Location

Furiex Research Site

Tiffin, Ohio, 44883, United States

Location

Furiex Research Site

Toledo, Ohio, 43615, United States

Location

Furiex Research Site

Norman, Oklahoma, 73071, United States

Location

Furiex Research Site

Oklahoma City, Oklahoma, 73102, United States

Location

Furiex Research Site

Oklahoma City, Oklahoma, 73112, United States

Location

Furiex Research Site

Portland, Oregon, 97210, United States

Location

Furiex Research Site

Salem, Oregon, 97301, United States

Location

Furiex Research Site

Carnegie, Pennsylvania, 15106, United States

Location

Furiex Research Site

Philadelphia, Pennsylvania, 19107, United States

Location

Furiex Research Site

Pittsburgh, Pennsylvania, 15206, United States

Location

Furiex Research Site

Pittsburgh, Pennsylvania, 15243, United States

Location

Furiex Research Site

Scottdale, Pennsylvania, 15683, United States

Location

Furiex Research Site

Uniontown, Pennsylvania, 15401, United States

Location

Furiex Research Site

Warwick, Rhode Island, 02888, United States

Location

Furiex Research Site

Anderson, South Carolina, 29621, United States

Location

Furiex Research Site

Columbia, South Carolina, 29201, United States

Location

Furiex Research Site

Columbia, South Carolina, 29203, United States

Location

Furiex Research Site

Columbia, South Carolina, 29204, United States

Location

Furiex Research Site

Easley, South Carolina, 29640, United States

Location

Furiex Research Site

Mt. Pleasant, South Carolina, 29464, United States

Location

Furiex Research Site

North Myrtle Beach, South Carolina, 29582, United States

Location

Furiex Research Site

Rapid City, South Dakota, 57702, United States

Location

Furiex Research Site

Athens, Tennessee, 37303, United States

Location

Furiex Research Site

Chattanooga, Tennessee, 37404, United States

Location

Furiex Research Site

Columbia, Tennessee, 38401, United States

Location

Furiex Research Site

Jackson, Tennessee, 38305, United States

Location

Furiex Research Site

Knoxville, Tennessee, 37919, United States

Location

Furiex Research Site

Smyrna, Tennessee, 37167, United States

Location

Furiex Research Site

Austin, Texas, 78745, United States

Location

Furiex Research Site

Beaumont, Texas, 77701, United States

Location

Furiex Research Site

Bedford, Texas, 76021, United States

Location

Furiex Research Site

Corsicana, Texas, 75110, United States

Location

Furiex Research Site

Dallas, Texas, 75218, United States

Location

Furiex Research Site

Dallas, Texas, 75225, United States

Location

Furiex Research Site

Fort Worth, Texas, 76133, United States

Location

Furiex Research Site

Frisco, Texas, 75035, United States

Location

Furiex Research Site

Houston, Texas, 77008, United States

Location

Furiex Research Site

Houston, Texas, 77043, United States

Location

Furiex Research Site

Houston, Texas, 77062, United States

Location

Furiex Research Site

Humble, Texas, 77338, United States

Location

Furiex Research Site

Hurst, Texas, 76054, United States

Location

Furiex Research Site

San Antonio, Texas, 78215, United States

Location

Furiex Research Site

San Antonio, Texas, 78229, United States

Location

Furiex Research Site

San Antonio, Texas, 78258, United States

Location

Furiex Research Site

Bountiful, Utah, 84010, United States

Location

Furiex Research Site

Salt Lake City, Utah, 84124, United States

Location

Furiex Research Site

West Valley City, Utah, 84120, United States

Location

Furiex Research Site

Burlington, Vermont, 05401, United States

Location

Furiex Research Site

Alexandria, Virginia, 22304, United States

Location

Furiex Research Site

Christiansburg, Virginia, 24073, United States

Location

Furiex Research Site

Midlothian, Virginia, 23114, United States

Location

Furiex Research Site

Norfolk, Virginia, 23502, United States

Location

Furiex Research Site

Richmond, Virginia, 23233, United States

Location

Furiex Research Site

Richmond, Virginia, 23235, United States

Location

Furiex Research Site

Charleston, West Virginia, 25304, United States

Location

Furiex Research Site

Monroe, Wisconsin, 53566, United States

Location

Furiex Research Site

Kelowna, British Columbia, V1Y 3G8, Canada

Location

Furiex Research Site

St. John's, Newfoundland and Labrador, A1E 2E2, Canada

Location

Furiex Research Site

Burlington, Ontario, L7M 4Y1, Canada

Location

Furiex Research Site

Greater Sudbury, Ontario, P3E 1H5, Canada

Location

Furiex Research Site

Hawkesbury, Ontario, K6A 1A1, Canada

Location

Furiex Research Site

London, Ontario, N5W 6A2, Canada

Location

Furiex Research Site

Newmarket, Ontario, L3Y 5G8, Canada

Location

Furiex Research Site

Sarnia, Ontario, N7T 4X3, Canada

Location

Furiex Research Site

Toronto, Ontario, M6H 3M1, Canada

Location

Furiex Research Site

Vaughan, Ontario, L4L 4Y7, Canada

Location

Furiex Research Site

San Juan, 00926-2832, Puerto Rico

Location

Furiex Research Site

Chestfield, Kent, CT5 3QS, United Kingdom

Location

Furiex Research Site

Blackpool, Lancashire, FY4 3AD, United Kingdom

Location

Furiex Research Site

Birmingham, B15 2TH, United Kingdom

Location

Furiex Research Site

County Durham, DL14 6AD, United Kingdom

Location

Furiex Research Site

Coventry, CV2 2DX, United Kingdom

Location

Furiex Research Site

Durham, DH1 5TW, United Kingdom

Location

Furiex Research Site

Edinburgh, EH4 2XH, United Kingdom

Location

Furiex Research Site

Manchester, M23 9LT, United Kingdom

Location

Furiex Research Site

Sheffield, S10 2JF, United Kingdom

Location

Furiex Research Site

Wigan, WN1 2NN, United Kingdom

Location

Related Publications (2)

  • Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1021-1029.e6. doi: 10.1016/j.cgh.2017.01.026. Epub 2017 Feb 3.

  • Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS. Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med. 2016 Jan 21;374(3):242-53. doi: 10.1056/NEJMoa1505180.

MeSH Terms

Conditions

Irritable Bowel SyndromeColonic DiseasesColonic Diseases, FunctionalDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesColonic Pseudo-ObstructionDiarrheaSigns and Symptoms, Digestive

Interventions

eluxadoline

Condition Hierarchy (Ancestors)

Intestinal Pseudo-ObstructionIleusIntestinal ObstructionSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Therapeutic Area Head
Organization
Allergan

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2012

First Posted

March 14, 2012

Study Start

May 29, 2012

Primary Completion

January 9, 2014

Study Completion

January 9, 2014

Last Updated

July 30, 2018

Results First Posted

July 30, 2018

Record last verified: 2018-07

Locations